• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Drug-induced autoimmune hepatitis: A minireview

    2022-07-08 03:06:04ChinKimgTanDanielleHoLaiMunWangRahulKumar
    World Journal of Gastroenterology 2022年24期

    Chin Kimg Tan, Danielle Ho,Lai Mun Wang, Rahul Kumar

    Abstract Drug-induced autoimmune hepatitis (DIAIH) is a specific phenotype of druginduced liver injury that may lead to the devastating outcome of acute liver failure requiring liver transplantation. Drugs implicated in DIAIH include antimicrobials such as nitrofurantoin and minocycline, non-steroidal anti-inflammatory drugs, statins as well as anti-tumor necrosis agents. The clinical features of druginduced liver injury are indistinguishable from idiopathic autoimmune hepatitis(AIH) as both may have positive AIH-related autoantibodies, elevated immunoglobulin G, as well as similar histopathological findings. In patients who show no clinical improvement, or there is progressive liver injury despite cessation of the suspected drug, a liver biopsy should be considered, whereby the presence of advance fibrosis on histology favors the diagnosis of idiopathic AIH. Empirical treatment with corticosteroids may be required in patients with non-resolving liver injury. A typical clinical scenario supportive of DIAIH includes a history of drug exposure with spontaneous resolution of liver injury after drug withdrawal and the absence of relapse after rapid steroid taper. In this article we report two cases of DIAIH secondary to Sorafenib and Atorvastatin along with a review of currently available literature. Early identification and treatment often lead to a favorable outcome in DIAIH.

    Key Words: Drug-induced liver injury; Drug-induced autoimmune hepatitis; Autoimmune hepatitis; Review

    INTRODUCTION

    Idiosyncratic drug-induced liver injury (DILI) is rare and affects 14-19 per 100000 persons yearly[1,2].Despite its relatively low incidence, it is a leading cause of acute liver failure in the United States[3],Europe[4,5], and Japan[6]. In patients with DILI, liver-related death and liver transplantation occur in 3.6%-10% of cases[7].

    Drug-induced autoimmune hepatitis (DIAIH) is a specific phenotype of idiosyncratic DILI with features indistinguishable from idiopathic autoimmune hepatitis (AIH), as it shares serological markers and/or histological features with idiopathic AIH[8]. Various terms have been used synonymously with DIAIH, including immune-mediated DILI[9] and drug-induced AIH-like injury[10].

    Due to its rare occurrence, it is difficult to estimate the frequency of DIAIH. In addition, studies use varying definitions of DIAIH and drug causality assessments, as well as having diverse patient populations with different follow-up periods (Tables 1 and 2). It is estimated that DIAIH accounts for 2%-18% of AIH cases[10-14], and 2.9%-8.8% of all DILI are due to DIAIH[15,16]. The increasing incidence of AIH has been in part attributed to prevalent use of anti-tumor necrosis factor agents[14].

    DRUGS ASSOCIATED WITH DIAIH

    Multiple drugs that have been associated with DIAIH are classified into those with definite association (e.g., Minocycline, Nitrofurantoin, Infliximab), probable association (e.g., Diclofenac, Atorvastatin,Rosuvastatin, Etanercept), and possible association, depending on the cases reported and associations as summarized in the most recent American Association Society of Liver Disease AIH Practice Guidance[10].

    DIAIH is classically associated with minocycline, nitrofurantoin, methyldopa, dihydralazine, and tienilic acid[17]. DILI with autoimmune phenotype defined as DILI with presence of AIH antibodies(antibodies to nuclear antigen, smooth muscle, and soluble liver antigen) occur in 83%, 74%, 60%, and 43% of nitrofurantoin, minocycline, methyldopa, and hydralazine related DILI cases, respectively[15].Immuno-allergic phenotype characterized by any combination of rash, fever, facial edema, lymphadenopathy, and eosinophilia is common in DILI associated with these four drugs as well, ranging from 11%-27%[15]. Another important cause of DIAIH include statins, where DIAIH or DILI with immune features occurs in about 8.5%-27.2% of all statin related DILI[18,19].

    In recent years, there has been a change in the predominant culprit drugs causing DIAIH to antitumor necrosis factor[14], statins, and non-steroidal anti-inflammatory drugs[16,20,21] with notable contribution from complementary alternative medicines in studies from Asia[22].

    PATHOGENESIS OF DIAIH

    Reactive metabolites generated from hepatic metabolism of drugs bind to cellular proteins such as components of CYP450, which is then recognized as neoantigens by heightened immunological response leading to AIH[11,23,24] as a result of misdirected immune response against self[25].

    In this minireview, we highlight two recent cases of DIAIH induced by Sorafenib and Atorvastatin seen at our center. We also aim to review the current literature on DIAIH and discuss distinguishing features between DIAIH and AIH.

    Table 1 Studies comparing drug-induced autoimmune hepatitis and drug-induced liver injury

    CASE DISCUSSION

    Patient A

    A 61-year-old man and teetotaler presented with a 1-week history of jaundice and malaise. He was on Atorvastatin 40 mg daily for 4 years for hyperlipidemia. He had a normal liver function test (LFT) prior to admission. He was started on Sorafenib 6 wk prior to presentation with jaundice for recurrent sarcoma of the left thigh. Clinical examination was unremarkable apart from scleral icterus. The LFT showed severe hepatocellular (HC) injury [bilirubin 4.56 mg/dL, alkaline phosphatase (ALP) 190 U/L,alanine transaminase (ALT) 1004 U/L, aspartate transaminase (AST) 790 U/L, international normalized ratio (INR) of 1.53]. Viral hepatitis screen, AIH-specific antibodies, and abdominal imaging were unremarkable. Of note, serum immunoglobulin G (IgG) was elevated (18.6 g/L). The liver biopsy showed features supportive of DILI and AIH (Figure 1). The Simplified AIH score was 6. The Roussel Uclaf Causality Assessment Model (RUCAM) score was 9 for Sorafenib and 6 for Atorvastatin.Diagnosis of Sorafenib-induced AIH was made. His LFT improved spontaneously with normalization of LFT 8 wk after stopping Sorafenib (Figure 2A).

    Patient B

    A 65-year-old man who was on Atorvastatin 40 mg daily presented with an incidental finding of acute HC pattern of liver injury 18 mo after initiation of Atorvastatin (albumin 39 g/L, globulin 39 g/L,bilirubin 0.64 mg/dL, ALP 107 IU/L, ALT 696 U/L, AST 381 U/L). Viral hepatitis screening, AIHspecific antibodies, and abdominal imaging were unremarkable. His serum IgG was normal (14.28 g/L).Atorvastatin was stopped, and an improvement in LFT was noted within the 1 wk (albumin ALT 474 U/L, AST 195 U/L). The RUCAM score for Atorvastatin was 4. As such, he was given the diagnosis of possible Atorvastatin-induced DILI. However, despite this initial improvement in his LFT, there was subsequent deterioration 2 wk after stopping Atorvastatin (albumin 34 g/L, globulin 43 g/L, ALP 137U/L, ALT 1404 U/L, AST 676 U/L, INR 1.09). A liver biopsy was performed 3 wk after stopping Atorvastatin in view of worsening acute liver injury. This showed marked HC injury with histological features suggestive of AIH (Figure 3). Following the liver biopsy, there was again spontaneous improvement (ALT 699 U/L), but this did not persist. Two months after cessation of Atorvastatin, he had severe HC injury with jaundice (bilirubin 11.87 mg/dL, ALP 96 U/L, ALT 1095 U/L, AST 938 U/L,INR 1.33) and elevated IgG (28.35 g/L). Liver biopsy was repeated, and this again demonstrated features of AIH. He was then started on prednisolone with rapid improvement of LFT (Figure 2Β). The final diagnosis was Atorvastatin-induced AIH.

    Table 2 Studies comparing drug-induced autoimmune hepatitis and autoimmune hepatitis

    WHEN TO SUSPECT DIAIH IN PATIENTS WHO PRESENTS WITH DILI

    The cases described above highlight two possible presentations of DIAIH. The first patient (patient A)had DILI and histological features compatible with AIH on liver biopsy. Although Sorafenib has not been reported to be associated with DIAIH, the temporal sequence of this case presentation and subsequent spontaneous resolution after cessation of Sorafenib is in keeping with DIAIH.

    DIAIH shares many similar characteristics with DILI without features of AIH. More than half of DIAIH present with acute liver injury associated with jaundice in 70%-75% of cases[16], which is similar to DILI. On top of that, rash may be present in 4.5% of DIAIH and 7.9% of DILI[26].

    The following pointers are useful in identification of DIAIH in patients who present with DILI. The main differences between these two conditions are also summarized in Table 3: (1) DIAIH and AIH should always be considered as differentials in a patient with a hepatocellular pattern of DILI. DIAIH is rarely associated with a cholestatic/mixed picture, and it is only seen in 8% of cases[16]; (2) A detailed medication history with a focus on recent drug exposures including complementary alternative medicines is essential[10]; (3) The latency period of drug exposure in DIAIH is usually prolonged compared to other types of DILI, some with a latency period exceeding 1 year,e.g., nitrofurantoin and minocycline[15]; (4) Seropositivity for AIH antibodies,e.g., antinuclear antibody (ANA), anti-smooth muscle antibody, anti-liver kidney antibody, and elevated serum IgG suggest possible DIAIH.However, not all patients with DIAIH have detectable autoantibodies or elevated IgG. Similarly, a proportion of patients with DILI may have detectable AIH antibodies[15,16]; (5) In the presence of detectable AIH antibodies and elevated IgG, AIH scoring (either pre-treatment score for Revised International AIH Group criteria[27] or simplified AIH score[28]) is useful to assess for possible orprobable AIH; (6) Liver-specific causality assessment tools may be used to ascertain the strength of association between drug exposure and clinical manifestation,e.g., RUCAM[29]; and (7) Liver biopsy is the cornerstone for the diagnosis of DIAIH and should be considered in the following scenarios: (a) Non resolving or worsening liver injury despite stopping possible culprit drugs; (b) Seropositivity of AIH antibodies, raised IgG, or possible AIH based on AIH scoring systems.

    Figure 1 Liver biopsy specimen for patient A. A: Low power view [hematoxylin & eosin (H&E) 100 ×] displays conspicuous portal and lobular inflammation with lobular disarray. Mild steatosis is also noted; B: Higher magnification of the portal tract (H&E 200 ×), zone 1, shows moderate chronic inflammation,lymphoplasmacytic predominantly, and rare eosinophils, with interface damage; C: At similar magnification (H&E 200 ×), the lobule including the perivenular region,e.g., zones 2 and 3, exhibits lobulitis characterized by aggregates of plasma cells, swollen hepatocytes with rosetting, Councilman bodies, and hepatocyte drop-out;D: High power view (H&E 400 ×) demonstrates rosetting of hepatocytes with droplets of orange-brown bile pigment; E and F: Histochemical stains Masson trichrome(E, 40 ×) showing collapse with mild early young fibrosis and Victoria blue (F, 40 ×) revealing paucity of elastic fibers, thus in keeping with subacute injury. Overall,the appearances are supportive of subacute drug-induced liver injury in association with autoimmune hepatitis histological pattern.

    Known culprit drugs of DIAIH such as nitrofurantoin may be overlooked as these agents are associated with longer latency period and have a lower ALT at presentation. A higher fibrosis stage or cirrhosis may be observed as a higher proportion of these patients are unknowingly continued on Nitrofurantoin prior to the diagnosis[30]. This underscores the importance of understanding the common culprits of DIAIH, where a significant proportion of DILI presents with DIAIH[15]. LiverTox?is an up-to-date online resource that provides information on hepatotoxicity caused by medications and supplements[31].

    With the increasing use of targeted tumor therapies such as kinase inhibitor and immunotherapy,there are some case reports of DIAIH associated with these medications. To our knowledge, this is the first case report of Sorafenib-induced AIH. Imatinib, another type of kinase inhibitor, has also been reported to be associated with DIAIH[14,32].

    Several studies have attempted to compare the differences between DIAIH and DILI (Table 1)[15,16,22], with key features of DIAIH including significantly longer duration of drug exposure and latency;higher ALT and AST; higher proportion of patients with positive ANA and SMA, and higher level of serum IgG, as summarized in Table 3.

    Liver biopsy is key in differentiating DIAIH from DILI without features of AIH[10,33]. In patients with DIAIH, the histopathological features are similar to that of idiopathic AIH with significantly higher proportion of patients showing severe portal inflammation, prominent portal-plasma cells, rosettes, and severe focal necrosis as compared to other types of DILI[16].

    Figure 2 Bilirubin and alanine transaminase trend for patients A and B. A: Patient A; B: Patient B.

    Though there is no significant difference in the severity and outcomes of DIAIH compared to other types of DILI, it is crucial to identify DIAIH in patients who present with DILI, as DIAIH may require treatment with immunosuppressants if liver injury does not improve with cessation of possible culprit drugs[10,31,33]. A significantly higher proportion of patients (50% to 80%) with DIAIH are treated with corticosteroids/immunosuppressants as compared to non-DIAIH DILI, and DIAIH will need longer term follow up even when LFT normalizes as late relapses may occur in up to 50% of cases where immunosuppressants are stopped[22]. Majority of relapses occur within a year, but some may present late up to 3 years after the initial diagnosis, and risk factors for late disease recurrence are not clear.

    Figure 3 Liver biopsy findings for patient B. A: Low power view [hematoxylin & eosin (H&E) 100 ×] shows portal and lobular inflammation with lobular disarray and mild steatosis; B: Higher magnification of the portal tract (H&E 200 ×) demonstrates moderate plasma cell-rich chronic inflammation with continuous interface damage; C: Lobulitis with aggregates of plasma cells and rosetting of hepatocytes is present in the lobule (H&E 200 ×); D and E: Masson trichrome (D, 40 ×)and Victoria blue (E, 40 ×) display mild early young fibrosis and paucity of elastic fibers, respectively. The absence of old mature type fibrosis suggested not a chronic injury. The autoimmune hepatitis histological pattern observed was therefore interpreted to be drug related, atorvastatin-induced.

    DIFFERENTIATING DIAIH AND IDIOPATHIC AIH

    The second case highlights the difficulty in differentiating DIAIH from idiopathic AIH. Βoth conditions have overlapping clinical presentations with HC pattern of liver injury and may have detectable ANA,SMA, and raised IgG in some cases[10,11]. A number of studies compared the difference between DIAIH and AIH (Table 2), with the key differences summarized in Table 4. Some useful features to distinguish between these two entities:

    Clinical presentation

    Majority (60%-83%) of DIAIH present with an acute presentation, whereas it is seen in less than 20%-35% of cases with idiopathic AIH[10,34]. Most studies of the two conditions do not demonstrate a significant difference in LFT levels[14,21,30,34], but ALT[13,30,34], AST[14,34], and bilirubin[14,34] tend to be higher in patients with DIAIH. Only one study[20] showed a significantly higher level of bilirubin,AST, and ALT in patients with DIAIH. There was no significant difference in the proportion of patients with detectable ANA (77-94%)[20,21] and elevated IgG (36%-59%)[14], although one study showed AIH had higher level of serum IgG compared to DIAIH; it was not, however, statistically significant[14].Immuno-allergic presentation with skin rash, fever, lymphadenopathy, and eosinophilia favor DIAIH,as it may occur in up to 30% of DIAIH[10,11].

    AIH scoring and causality assessment

    In a cohort of 44 patients with DIAIH and AIH, the simplified AIH score was not useful in differentiating the two entities[21]. Of note, patients with AIH had significantly higher pre-treatment AIH score compared to patients with DIAIH. The sensitivity and the specificity for pre-treatment AIH score (using a cut off of ≥ 12 – probable AIH) was shown to be 59% and 82%, respectively. As for RUCAM, using a cut off of ≥ 6 (probable), the specificity reaches 91%, albeit with a low sensitivity at 32%. When these are used in combination, there is still a potential for misdiagnosis in up to 11% of patients.

    Histopathology

    Βoth DIAIH and AIH share similar histological findings (portal and periportal infiltrates of lymphocytes, lobular hepatitis, plasma cells, and eosinophils) with no clear differentiating features,except presence of advance fibrosis or cirrhosis favoring idiopathic AIH[11,34]. However, a significantly higher proportion of patients with AIH showed typical features of AIH (54%) as compared to DIAIH(18.2%)[20], specifically in terms of portal inflammation with interface hepatitis and plasma cell infiltrates. The same study also found that DIAIH tended to have more eosinophilic infiltrates, which was not noted in other studies[21].

    Treatment and response to treatment

    The cornerstone in the management of DIAIH is to stop the culprit drug. Spontaneous improvement of LFT may then occur, as was observed in patient A. The most consistent and significant differentiating feature between DIAIH and AIH in published case series thus far lies in the response to treatment(Table 4). In cases where liver injury does not resolve despite cessation of the culprit drug or where the degree of DILI is severe, corticosteroids are usually started as per the initial management of AIH. Most studies on DIAIH exclusively include patients who were treated with immunosuppressants[14,20,21,30]. Βoth DIAIH and AIH showed excellent response to corticosteroids, with remission rate exceeding 90% in most cases[21,30-34].

    It should be borne in mind that there is discrepancy in literature regarding the mean time to achieve immunosuppression induced remission in DIAIH and AIH. While one study demonstrated similar 3 mo mean time to remission[21] in both conditions, another showed a significant difference, where DIAIH took a significantly shorter time than AIH to achieve remission[34] (2 movs16.8 mo). This may be attributed to the heterogeneity of the study population. Resolution of DIAIH usually occurs after 1 mo(rarely up to 3 mo) of immunosuppression. Unlike in AIH, DIAIH rarely requires long term immunosuppression and has very low relapse rates after cessation of immunosuppressants over a long follow-up of up to 4 years[10,11,13-15,20,21,34] (Table 2). In cases where DIAIH relapses, the time to relapse is significantly longer compared to AIH[30], which implies that patients with DIAIH will require a longer period of follow-up after resolution of liver injury as compared to the usual DILI. Interestingly,despite similar time to remission in the two groups, Weberet al[21] showed that an early rapid response to corticosteroid treatment differentiates DIAIH from AIH with good sensitivity and specificity at 77%,respectively. The early rapid response was defined by 9% drop of ALT per day in the first week of corticosteroid therapy.

    The use of steroids appears to be a promising means of differentiating DIAIH or AIH in the early course of disease with better sensitivity than RUCAM and AIH score[21]. This also has the potential benefit of avoiding long term immunosuppressive therapy in DIAIH. Also, in 30%-35% of DIAIH cases that were initially seropositive for ANA and SMA, the antibodies became undetectable at 6 mo following the initial DILI, which was independent of treatment with corticosteroids[15].

    Major hepatology society guidelines recommend a similar approach in terms of corticosteroids initiation in non-resolving DIAIH and AIH[10,11]. However, there is no consensus regarding treatment duration and methods to confirm remission before discontinuation of immunosuppressants. Thus, the decision and timing to stop treatment should be assessed on case-by-case basis[10]. In fact, one study has shown success in tapering off immunosuppression within 3-17 mo without evidence of relapse[20].

    Risk alleles and monocyte-derived hepatocyte like cells

    Risk alleles for idiopathic AIH such as HLA DRΒ1 DRΒ1*03:01 or DRΒ1*04:01 are uncommon in DIAIH and, if this is detected, may favor a diagnosis of AIH[10]. The MetaHeps?test, which uses monocytederived hepatocyte-like cells, has been used to differentiate DIAIH from AIH with high sensitivity and specificity[21]. However, this test is not readily available, thereby limiting its utility in clinical practice.The lymphocyte toxicity assay described by Neumanet al[35] can sometimes be helpful in differentiating drug hypersensitivity syndromes from idiopathic AIH as well.

    Outcomes

    The long-term outcome of DIAIH is excellent with a survival rate between 90%-100% without liver transplantation[10]. This is in contrast with idiopathic AIH, where there is a high risk of relapse upon treatment withdrawal and risk of progression to cirrhosis, resulting in the need for liver transplantation[10,11,34]. It is also noteworthy that DIAIH can lead to chronic DILI with abnormal LFT lasting more than 6 mo in 17%-22% of cases[15,36].

    CONCLUSION

    In summary, it is important to differentiate between DIAIH and AIH in patients who present with DILI,as the management and outcome differ. Early recognition of DIAIH is key as the mainstay of management is cessation of culprit drug and in some cases, initiation of corticosteroids with the aim to avoid long-term immunosuppression.

    ACKNOWLEDGEMENTS

    We acknowledge all our colleagues in the Department of Gastroenterology and Hepatology and Pathology at Changi General Hospital who help manage the 2 patients described in the manuscript. We would also like to thank the 2 patients described here who readily consented to be described in this manuscript.

    FOOTNOTES

    Author contributions:Kumar R and Tan CK conceptualized the study; Tan CK, Ho D, and Kumar R wrote the initial manuscript; Wand LM provided critical input and histo-pathological slides for the manuscript; all authors were involved in the critical revision.

    Conflict-of-interest statement:All authors have no relevant conflict of interest to report.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC ΒYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:Singapore

    ORCID number:Chin Kimg Tan 0000-0002-3918-4340; Danielle Ho 0000-0003-0652-406x; Lai Mun Wang 0000-0001-7113-4215; Rahul Kumar 0000-0002-5092-4821.

    S-Editor:Yan JP

    L-Editor:Filipodia

    P-Editor:Yan JP

    综合色av麻豆| 亚洲成av人片免费观看| 欧美日韩福利视频一区二区| 亚洲av成人精品一区久久| 久久久久国产精品人妻aⅴ院| 波多野结衣高清无吗| 亚洲av免费在线观看| 夜夜爽天天搞| 又爽又黄无遮挡网站| 看片在线看免费视频| h日本视频在线播放| 无遮挡黄片免费观看| 欧美一区二区国产精品久久精品| 可以在线观看的亚洲视频| 久久国产精品人妻蜜桃| 亚洲电影在线观看av| 国内揄拍国产精品人妻在线| 午夜亚洲福利在线播放| av片东京热男人的天堂| 国产伦在线观看视频一区| 免费在线观看影片大全网站| www.999成人在线观看| 麻豆成人av在线观看| 国产高清三级在线| 色老头精品视频在线观看| 在线视频色国产色| 最近最新中文字幕大全免费视频| 校园春色视频在线观看| 婷婷精品国产亚洲av| 国产一区在线观看成人免费| 国产精品 国内视频| 亚洲av电影不卡..在线观看| 又黄又爽又免费观看的视频| 少妇丰满av| 日本免费a在线| 两人在一起打扑克的视频| 久久久久久久久中文| 国产极品精品免费视频能看的| 日本熟妇午夜| 好男人在线观看高清免费视频| 99在线视频只有这里精品首页| www.熟女人妻精品国产| 全区人妻精品视频| 天堂√8在线中文| 亚洲色图 男人天堂 中文字幕| 国产综合懂色| 黄色 视频免费看| 99精品欧美一区二区三区四区| 日韩高清综合在线| 欧美大码av| 又黄又爽又免费观看的视频| 久久精品国产清高在天天线| 高清毛片免费观看视频网站| 精品国内亚洲2022精品成人| 18禁观看日本| 美女高潮喷水抽搐中文字幕| 日韩欧美国产一区二区入口| 少妇的丰满在线观看| x7x7x7水蜜桃| 亚洲av电影不卡..在线观看| 99视频精品全部免费 在线 | 在线播放国产精品三级| 国产精品一区二区精品视频观看| 亚洲av美国av| 无人区码免费观看不卡| 无限看片的www在线观看| 日本与韩国留学比较| 舔av片在线| 亚洲欧美激情综合另类| 欧美日韩国产亚洲二区| 日韩人妻高清精品专区| 国产野战对白在线观看| a级毛片a级免费在线| 亚洲色图 男人天堂 中文字幕| 国产日本99.免费观看| 欧美一级毛片孕妇| 色综合欧美亚洲国产小说| www.熟女人妻精品国产| 亚洲精品在线美女| 淫秽高清视频在线观看| 久久久久性生活片| 色老头精品视频在线观看| 国产高清激情床上av| 午夜福利在线观看吧| av黄色大香蕉| 亚洲av成人一区二区三| 久久久久国产精品人妻aⅴ院| 婷婷亚洲欧美| 午夜两性在线视频| 伊人久久大香线蕉亚洲五| 精华霜和精华液先用哪个| 五月玫瑰六月丁香| 俄罗斯特黄特色一大片| 亚洲精品久久国产高清桃花| 国产又黄又爽又无遮挡在线| 老熟妇仑乱视频hdxx| 久久久久久大精品| 成人三级做爰电影| 午夜福利在线观看免费完整高清在 | 99热6这里只有精品| 亚洲午夜理论影院| 国产男靠女视频免费网站| 极品教师在线免费播放| 国产人伦9x9x在线观看| 日韩人妻高清精品专区| 亚洲av熟女| 国产成人啪精品午夜网站| 又紧又爽又黄一区二区| 成年女人永久免费观看视频| 亚洲欧美精品综合久久99| 亚洲午夜精品一区,二区,三区| 九九久久精品国产亚洲av麻豆 | 岛国在线观看网站| 在线观看一区二区三区| 日韩欧美一区二区三区在线观看| 超碰成人久久| 女同久久另类99精品国产91| 日韩欧美 国产精品| 亚洲欧美日韩无卡精品| 岛国视频午夜一区免费看| 亚洲五月天丁香| 午夜福利成人在线免费观看| 美女被艹到高潮喷水动态| 国产视频一区二区在线看| 久久亚洲精品不卡| 51午夜福利影视在线观看| 三级毛片av免费| 啦啦啦观看免费观看视频高清| 国产精品一区二区三区四区免费观看 | 人妻夜夜爽99麻豆av| 19禁男女啪啪无遮挡网站| 午夜激情欧美在线| 国产精品乱码一区二三区的特点| 国产成年人精品一区二区| 亚洲av熟女| 夜夜夜夜夜久久久久| 欧美日韩国产亚洲二区| 两个人的视频大全免费| 噜噜噜噜噜久久久久久91| 亚洲精品456在线播放app | 精品一区二区三区视频在线 | 日韩欧美精品v在线| 啪啪无遮挡十八禁网站| 丁香六月欧美| 国产不卡一卡二| 性色avwww在线观看| 看免费av毛片| 久久久国产欧美日韩av| 毛片女人毛片| 一个人看视频在线观看www免费 | 一进一出抽搐动态| 两性午夜刺激爽爽歪歪视频在线观看| 深夜精品福利| 亚洲精品456在线播放app | 岛国在线免费视频观看| 十八禁人妻一区二区| 久久热在线av| 亚洲国产精品sss在线观看| 母亲3免费完整高清在线观看| 国产高清三级在线| 日韩精品青青久久久久久| 一夜夜www| 高清在线国产一区| 老司机在亚洲福利影院| 亚洲午夜理论影院| 国产1区2区3区精品| 亚洲成人免费电影在线观看| 日韩精品青青久久久久久| 久久久水蜜桃国产精品网| 好男人在线观看高清免费视频| 欧美中文综合在线视频| 成人永久免费在线观看视频| 又紧又爽又黄一区二区| 日韩欧美精品v在线| 视频区欧美日本亚洲| 最新在线观看一区二区三区| 999久久久精品免费观看国产| 综合色av麻豆| 亚洲av成人精品一区久久| 人人妻人人澡欧美一区二区| 久久性视频一级片| 欧美日韩瑟瑟在线播放| 噜噜噜噜噜久久久久久91| 欧美中文综合在线视频| 欧美日本亚洲视频在线播放| 毛片女人毛片| 亚洲av五月六月丁香网| 成在线人永久免费视频| 日韩大尺度精品在线看网址| 在线观看一区二区三区| 99久久精品国产亚洲精品| 一级黄色大片毛片| 亚洲无线在线观看| 最近最新中文字幕大全电影3| 欧美又色又爽又黄视频| 嫩草影院入口| 国产精品亚洲美女久久久| 国产精品一及| 精品午夜福利视频在线观看一区| 欧美一区二区精品小视频在线| 18禁美女被吸乳视频| 久久人妻av系列| 国产精品影院久久| 久久性视频一级片| 国产伦一二天堂av在线观看| 久久久水蜜桃国产精品网| 欧美丝袜亚洲另类 | 91久久精品国产一区二区成人 | 亚洲欧美日韩东京热| 美女黄网站色视频| 成人亚洲精品av一区二区| 日韩欧美 国产精品| 亚洲国产精品成人综合色| 99热精品在线国产| 精品国产美女av久久久久小说| 美女 人体艺术 gogo| 国语自产精品视频在线第100页| 亚洲中文av在线| 亚洲国产中文字幕在线视频| 久久人人精品亚洲av| 久久久久国内视频| 757午夜福利合集在线观看| 免费高清视频大片| 特大巨黑吊av在线直播| 国产男靠女视频免费网站| 嫁个100分男人电影在线观看| 久久久久免费精品人妻一区二区| 长腿黑丝高跟| 国产aⅴ精品一区二区三区波| 国产av在哪里看| 日韩高清综合在线| 亚洲色图av天堂| 视频区欧美日本亚洲| 黄色丝袜av网址大全| 国产三级在线视频| 欧美日韩福利视频一区二区| 亚洲精品在线美女| 18美女黄网站色大片免费观看| 人人妻人人看人人澡| 精品国产美女av久久久久小说| 国产视频内射| 亚洲专区中文字幕在线| 香蕉国产在线看| 久久久久国产精品人妻aⅴ院| 成年女人永久免费观看视频| 亚洲欧美日韩高清在线视频| 蜜桃久久精品国产亚洲av| av在线蜜桃| cao死你这个sao货| 国产精品亚洲美女久久久| 国产欧美日韩精品亚洲av| 亚洲avbb在线观看| 美女大奶头视频| 黄片大片在线免费观看| 国产黄片美女视频| 精品国产乱码久久久久久男人| 免费观看精品视频网站| 国产精品免费一区二区三区在线| www.精华液| 日本五十路高清| 成年人黄色毛片网站| 白带黄色成豆腐渣| 日本免费a在线| 亚洲 欧美一区二区三区| 亚洲美女视频黄频| 国产亚洲欧美98| 黄色 视频免费看| 天天躁日日操中文字幕| 日韩精品中文字幕看吧| 偷拍熟女少妇极品色| 久久国产精品人妻蜜桃| av国产免费在线观看| 日韩有码中文字幕| 身体一侧抽搐| 禁无遮挡网站| 熟女电影av网| 最近最新免费中文字幕在线| 婷婷亚洲欧美| 国产成人精品久久二区二区91| 亚洲午夜理论影院| 国产成人福利小说| 日韩大尺度精品在线看网址| 岛国视频午夜一区免费看| www.精华液| 日韩成人在线观看一区二区三区| e午夜精品久久久久久久| 人妻夜夜爽99麻豆av| 欧美成人一区二区免费高清观看 | 一本久久中文字幕| 又黄又爽又免费观看的视频| 亚洲精品中文字幕一二三四区| 国产激情偷乱视频一区二区| 老汉色av国产亚洲站长工具| 国内精品久久久久精免费| 国产伦精品一区二区三区视频9 | 免费在线观看日本一区| 天堂动漫精品| 午夜久久久久精精品| 一级a爱片免费观看的视频| 非洲黑人性xxxx精品又粗又长| 亚洲电影在线观看av| a级毛片在线看网站| 亚洲欧美日韩东京热| 成在线人永久免费视频| 久久精品国产综合久久久| 久久久水蜜桃国产精品网| 制服人妻中文乱码| 热99在线观看视频| 操出白浆在线播放| 香蕉久久夜色| 91麻豆av在线| 不卡av一区二区三区| 久久精品国产亚洲av香蕉五月| 一本一本综合久久| av福利片在线观看| 男女视频在线观看网站免费| 国产毛片a区久久久久| 免费看美女性在线毛片视频| 欧美乱码精品一区二区三区| 久久久国产精品麻豆| 99热精品在线国产| 国产一区二区在线av高清观看| 久久久久久久久免费视频了| 亚洲18禁久久av| 精品久久久久久久久久久久久| 美女午夜性视频免费| 美女高潮的动态| 此物有八面人人有两片| 99热6这里只有精品| 国产爱豆传媒在线观看| 亚洲成人久久爱视频| 两个人的视频大全免费| 成人av在线播放网站| 国内精品美女久久久久久| 18美女黄网站色大片免费观看| 岛国在线观看网站| 一个人观看的视频www高清免费观看 | 成人精品一区二区免费| 一区福利在线观看| 国内精品美女久久久久久| 国产高清视频在线观看网站| 一本一本综合久久| 午夜日韩欧美国产| 欧美在线黄色| 老鸭窝网址在线观看| 日韩欧美三级三区| 精品欧美国产一区二区三| 久久精品亚洲精品国产色婷小说| 97超视频在线观看视频| 免费在线观看成人毛片| 久久香蕉精品热| 国产精品精品国产色婷婷| 一本精品99久久精品77| 日本五十路高清| 热99re8久久精品国产| 日本免费一区二区三区高清不卡| 18禁黄网站禁片午夜丰满| 国产一级毛片七仙女欲春2| www.www免费av| 国产精品一区二区精品视频观看| 这个男人来自地球电影免费观看| 午夜两性在线视频| 国产欧美日韩一区二区精品| 国产乱人视频| 亚洲成a人片在线一区二区| 国产精品影院久久| 女人被狂操c到高潮| 午夜福利18| 国产日本99.免费观看| 精品人妻1区二区| 精品一区二区三区四区五区乱码| 亚洲真实伦在线观看| 非洲黑人性xxxx精品又粗又长| 日韩人妻高清精品专区| 亚洲欧美激情综合另类| 国产精品久久久av美女十八| 欧美极品一区二区三区四区| 日韩欧美一区二区三区在线观看| www.熟女人妻精品国产| 欧美黑人欧美精品刺激| 99热精品在线国产| 精品久久久久久久毛片微露脸| 麻豆一二三区av精品| 久久久久久久午夜电影| 午夜日韩欧美国产| 黄频高清免费视频| 白带黄色成豆腐渣| 十八禁人妻一区二区| 亚洲 欧美 日韩 在线 免费| 麻豆成人午夜福利视频| av天堂在线播放| 成人鲁丝片一二三区免费| 国产成人系列免费观看| svipshipincom国产片| 亚洲激情在线av| 久久久久久久久免费视频了| 国产一区二区在线av高清观看| 亚洲av中文字字幕乱码综合| 亚洲狠狠婷婷综合久久图片| 亚洲最大成人中文| 母亲3免费完整高清在线观看| 一级黄色大片毛片| 国产欧美日韩一区二区精品| 波多野结衣高清无吗| 日本黄色片子视频| 一a级毛片在线观看| 高清在线国产一区| 国产欧美日韩精品亚洲av| 国产激情欧美一区二区| 偷拍熟女少妇极品色| 国产精品乱码一区二三区的特点| 国产精品久久视频播放| 欧美日韩黄片免| 美女cb高潮喷水在线观看 | 又大又爽又粗| 一进一出抽搐gif免费好疼| 99久久国产精品久久久| 成人三级黄色视频| 老司机福利观看| 久久99热这里只有精品18| 国产av一区在线观看免费| 免费电影在线观看免费观看| 啦啦啦观看免费观看视频高清| 国产精品日韩av在线免费观看| 欧美高清成人免费视频www| 欧美日韩乱码在线| 国产精品1区2区在线观看.| 俺也久久电影网| 99久久久亚洲精品蜜臀av| 中文字幕精品亚洲无线码一区| 日本与韩国留学比较| 人妻久久中文字幕网| 国产免费av片在线观看野外av| 黑人欧美特级aaaaaa片| 国产一区二区激情短视频| 美女被艹到高潮喷水动态| 中文字幕熟女人妻在线| 亚洲欧美日韩东京热| 国产精品久久视频播放| 亚洲成人久久性| 老司机午夜十八禁免费视频| 精华霜和精华液先用哪个| a级毛片在线看网站| 在线观看66精品国产| 久久九九热精品免费| ponron亚洲| 美女高潮的动态| 男女下面进入的视频免费午夜| 中文在线观看免费www的网站| 哪里可以看免费的av片| 在线观看舔阴道视频| 国产成人精品久久二区二区91| 国产亚洲av高清不卡| 别揉我奶头~嗯~啊~动态视频| 亚洲精品在线观看二区| 美女扒开内裤让男人捅视频| 国产成年人精品一区二区| 亚洲中文日韩欧美视频| 国产三级在线视频| 法律面前人人平等表现在哪些方面| 日韩欧美三级三区| 亚洲成av人片在线播放无| 日日干狠狠操夜夜爽| 国产视频一区二区在线看| 亚洲人成电影免费在线| 18禁黄网站禁片免费观看直播| av黄色大香蕉| 成人特级av手机在线观看| 在线十欧美十亚洲十日本专区| 午夜福利在线观看吧| 12—13女人毛片做爰片一| 欧美丝袜亚洲另类 | 免费观看精品视频网站| 在线观看美女被高潮喷水网站 | 一本精品99久久精品77| 视频区欧美日本亚洲| www日本在线高清视频| 亚洲精品久久国产高清桃花| 久久精品人妻少妇| 欧美极品一区二区三区四区| 免费高清视频大片| 日韩国内少妇激情av| a在线观看视频网站| 欧美+亚洲+日韩+国产| 身体一侧抽搐| 亚洲一区高清亚洲精品| 国产精品一及| netflix在线观看网站| 99国产精品一区二区蜜桃av| 国产午夜福利久久久久久| 99久久精品国产亚洲精品| 国产精品av视频在线免费观看| 精品久久久久久久久久免费视频| 偷拍熟女少妇极品色| 久久国产精品影院| 国产成人av教育| 美女午夜性视频免费| 天堂网av新在线| av在线天堂中文字幕| 国产精品一区二区精品视频观看| 久久久色成人| av天堂在线播放| 午夜成年电影在线免费观看| 亚洲国产欧美人成| 老熟妇乱子伦视频在线观看| 别揉我奶头~嗯~啊~动态视频| 亚洲欧美日韩无卡精品| 一本精品99久久精品77| 天天添夜夜摸| 国产视频一区二区在线看| 精品无人区乱码1区二区| 精品国产三级普通话版| 啦啦啦观看免费观看视频高清| 免费看美女性在线毛片视频| 国产精品久久久久久久电影 | 99久久精品一区二区三区| 一夜夜www| 国产午夜福利久久久久久| 成年免费大片在线观看| 国产精品,欧美在线| 欧美高清成人免费视频www| 日本 欧美在线| 好男人电影高清在线观看| 熟女少妇亚洲综合色aaa.| 十八禁网站免费在线| 老司机深夜福利视频在线观看| 一本久久中文字幕| 久久久国产欧美日韩av| 亚洲在线自拍视频| 一个人免费在线观看电影 | 成年免费大片在线观看| 国产精品免费一区二区三区在线| 国产亚洲精品一区二区www| 亚洲精品久久国产高清桃花| 国产男靠女视频免费网站| 国产综合懂色| 日本免费a在线| 国内精品美女久久久久久| 99久国产av精品| 五月玫瑰六月丁香| 亚洲国产精品合色在线| 亚洲成人久久爱视频| 亚洲美女视频黄频| 成人精品一区二区免费| 一边摸一边抽搐一进一小说| 国产男靠女视频免费网站| 国产 一区 欧美 日韩| 成在线人永久免费视频| 久久精品91蜜桃| 欧美中文日本在线观看视频| 亚洲av美国av| 757午夜福利合集在线观看| 国产真实乱freesex| 国产精品香港三级国产av潘金莲| 丁香六月欧美| 91av网站免费观看| 欧美不卡视频在线免费观看| 在线观看午夜福利视频| 亚洲电影在线观看av| 久久久色成人| 99国产极品粉嫩在线观看| 国产精品久久电影中文字幕| 亚洲,欧美精品.| 成人一区二区视频在线观看| 亚洲精品色激情综合| 国内精品久久久久精免费| 男女床上黄色一级片免费看| 久久午夜综合久久蜜桃| 欧美黑人欧美精品刺激| 脱女人内裤的视频| 亚洲精品国产精品久久久不卡| 亚洲av中文字字幕乱码综合| 俄罗斯特黄特色一大片| 久久久久国产精品人妻aⅴ院| 午夜福利在线观看吧| 三级国产精品欧美在线观看 | 国产高清视频在线播放一区| 精品一区二区三区四区五区乱码| 久久久国产欧美日韩av| 校园春色视频在线观看| 18禁国产床啪视频网站| 中文字幕久久专区| 黄色视频,在线免费观看| 欧美激情久久久久久爽电影| 欧美成人一区二区免费高清观看 | 给我免费播放毛片高清在线观看| 久久久国产欧美日韩av| 日日夜夜操网爽| 欧美成人一区二区免费高清观看 | 久久人妻av系列| 欧美成人性av电影在线观看| 男人舔女人的私密视频| 最近最新中文字幕大全电影3| 91在线精品国自产拍蜜月 | 黄色视频,在线免费观看| 身体一侧抽搐| svipshipincom国产片| 免费大片18禁| 成人av一区二区三区在线看| 国产久久久一区二区三区| 亚洲性夜色夜夜综合| 人妻夜夜爽99麻豆av| 国产精品永久免费网站| 久久中文字幕人妻熟女| 12—13女人毛片做爰片一| 伦理电影免费视频| 亚洲精品中文字幕一二三四区| 欧美+亚洲+日韩+国产| 久久久久久久久免费视频了| 久久亚洲真实| 无遮挡黄片免费观看| 国产1区2区3区精品| 黄片大片在线免费观看| 最新中文字幕久久久久 | 亚洲国产欧美人成|